AB220,25,1616 chapter 50
AB220,25,1717 subchapter VI
AB220,25,1918 distribution and
19 testing centers
AB220,25,20 2050.80 Definitions. In this subchapter:
AB220,25,22 21(1) “Compassion center" means a licensed organization that grows, sells,
22distributes, or delivers marijuana for the medical use of tetrahydrocannabinols.
AB220,25,23 23(2) “Debilitating medical condition or treatment" means any of the following:
AB220,26,424 (a) Cancer; glaucoma; acquired immunodeficiency syndrome; a positive test for
25the presence of HIV, antigen or nonantigenic products of HIV, or an antibody to HIV;

1inflammatory bowel disease, including ulcerative colitis or Crohn's disease; a
2hepatitis C virus infection; Alzheimer's disease; amyotrophic lateral sclerosis; nail
3patella syndrome; Ehlers-Danlos Syndrome; post-traumatic stress disorder; or the
4treatment of these conditions.
AB220,26,85 (b) A chronic or debilitating disease or medical condition or the treatment of
6such a disease or condition that causes cachexia, severe pain, severe nausea,
7seizures, including those characteristic of epilepsy, or severe and persistent muscle
8spasms, including those characteristic of multiple sclerosis.
AB220,26,119 (c) Any other medical condition or any other treatment for a medical condition
10designated as a debilitating medical condition or treatment in rules promulgated by
11the department under s. 50.81 (2).
AB220,26,12 12(2m) “Department" means the department of health services.
AB220,26,14 13(3) “Maximum medicinal amount" means 6 live marijuana plants and 3 ounces
14of usable marijuana.
AB220,26,15 15(4) “Medical use of tetrahydrocannabinols" means any of the following:
AB220,26,1816 (a) The use of tetrahydrocannabinols in any form by a qualifying patient to
17alleviate the symptoms or effects of the qualifying patient's debilitating medical
18condition or treatment.
AB220,26,2119 (b) The acquisition, possession, cultivation, or transportation of
20tetrahydrocannabinols in any form by a qualifying patient if done to facilitate his or
21her use of tetrahydrocannabinols under par. (a).
AB220,27,222 (c) The acquisition, possession, cultivation, or transportation of
23tetrahydrocannabinols in any form by a primary caregiver of a qualifying patient,
24the transfer of tetrahydrocannabinols in any form between a qualifying patient and
25his or her primary caregiver, or the transfer of tetrahydrocannabinols in any form

1between persons who are primary caregivers for the same qualifying patient if all of
2the following apply:
AB220,27,53 1. The acquisition, possession, cultivation, or transportation of
4tetrahydrocannabinols is done to facilitate the qualifying patient's use of
5tetrahydrocannabinols under par. (a) or (b).
AB220,27,86 2. It is not practicable for the qualifying patient to acquire, possess, cultivate,
7or transport tetrahydrocannabinols independently, or the qualifying patient is under
818 years of age.
AB220,27,9 9(4m) “Physician” means a person licensed under s. 448.04 (1) (a).
AB220,27,12 10(5) “Primary caregiver" means a person who is at least 18 years of age and who
11has agreed to help a qualifying patient in his or her medical use of
12tetrahydrocannabinols.
AB220,27,15 13(6) “Qualifying patient" means a person who has been diagnosed by a physician
14as having or undergoing a debilitating medical condition or treatment but does not
15include a person under the age of 18 years unless all of the following apply:
AB220,27,1816 (a) The person's physician has explained the potential risks and benefits of the
17medical use of tetrahydrocannabinols to the person and to a parent, guardian, or
18individual who has legal custody of the person.
AB220,27,2019 (b) The parent, guardian, or individual who has legal custody of the person
20provides the physician a written statement consenting to do all of the following:
AB220,27,2121 1. Allow the person's medical use of tetrahydrocannabinols.
AB220,27,2222 2. Serve as a primary caregiver for the person.
AB220,27,2323 3. Manage the person's medical use of tetrahydrocannabinols.
AB220,27,24 24(7) “Registry identification card" has the meaning given in s. 146.44 (1) (h).
AB220,28,2
1(8) “Treatment team" means a qualifying patient and his or her primary
2caregivers.
AB220,28,3 3(9) “Usable marijuana" has the meaning given in s. 139.97 (13).
AB220,28,5 4(10) “Written certification" means a statement made by a person's physician
5if all of the following apply: